Paper26328536
Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices.
El-Laboudi AH and 1 other. Diabetes Ther, 2015. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices. Papers, record 26328536. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26328536
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Towards a Physiological Prandial Insulin Profile: Enhancement of Subcutaneously Injected Prandial Insulin Using Local Warming Devices.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| II-LA-0313-20004 | Department of Health | United Kingdom | PubMed | |
| MC_PC_12015 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20693354 | Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes. | Diabetes Care | 2010 | https://conductscience.org/library/papers/20693354 | PubMed |
| 2 | 18671795 | Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis. | Diabetes Obes Metab | 2009 | https://conductscience.org/library/papers/18671795 | PubMed |
| 3 | 24392996 | The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus. | Curr Med Res Opin | 2014 | https://conductscience.org/library/papers/24392996 | PubMed |
| 4 | 9892228 | Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. | Diabetes | 1999 | https://conductscience.org/library/papers/9892228 | PubMed |
| 5 | 25352633 | Improved insulin absorption by means of standardized injection site modulation results in a safer and more efficient prandial insulin treatment. A review of the existing clinical data. | J Diabetes Sci Technol | 2015 | https://conductscience.org/library/papers/25352633 | PubMed |
| 6 | 24367934 | Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming. | Diabetes Technol Ther | 2014 | https://conductscience.org/library/papers/24367934 | PubMed |
| 7 | 22920797 | Ultrafast-acting insulins: state of the art. | J Diabetes Sci Technol | 2012 | https://conductscience.org/library/papers/22920797 | PubMed |
| 8 | 24089542 | Needle-free jet injection of rapid-acting insulin improves early postprandial glucose control in patients with diabetes. | Diabetes Care | 2013 | https://conductscience.org/library/papers/24089542 | PubMed |
| 9 | 25113814 | Effect of local heating on postprandial blood glucose excursions using the InsuPad device: results of an outpatient crossover study. | J Diabetes Sci Technol | 2014 | https://conductscience.org/library/papers/25113814 | PubMed |
| 10 | 7000239 | Sauna-induced acceleration in insulin absorption from subcutaneous injection site. | Br Med J | 1980 | https://conductscience.org/library/papers/7000239 | PubMed |
| 11 | 25565442 | How to overcome the limitations of current insulin administration with new non-invasive delivery systems. | Ther Deliv | 2015 | https://conductscience.org/library/papers/25565442 | PubMed |
| 12 | 24610683 | Improved pharmacokinetic and pharmacodynamic profiles of insulin analogues using InsuPatch, a local heating device. | Diabetes Metab Res Rev | 2014 | https://conductscience.org/library/papers/24610683 | PubMed |
| 13 | 26037035 | Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear. | Drug Deliv Transl Res | 2015 | https://conductscience.org/library/papers/26037035 | PubMed |
| 14 | 24940825 | Standardized modulation of the injection site allows for insulin dose reduction without deterioration of metabolic control. | Curr Med Res Opin | 2014 | https://conductscience.org/library/papers/24940825 | PubMed |
| 15 | 25846340 | Faster-acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart. | Diabetes Obes Metab | 2015 | https://conductscience.org/library/papers/25846340 | PubMed |
| 16 | 19539098 | Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. | Clin Ther | 2009 | https://conductscience.org/library/papers/19539098 | PubMed |
| 17 | 12832307 | Comparison of insulin aspart and lispro: pharmacokinetic and metabolic effects. | Diabetes Care | 2003 | https://conductscience.org/library/papers/12832307 | PubMed |
| 18 | 21715522 | Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology. | Diabetes Care | 2011 | https://conductscience.org/library/papers/21715522 | PubMed |
| 19 | 20618882 | How pharmacokinetic and pharmacodynamic principles pave the way for optimal basal insulin therapy in type 2 diabetes. | Int J Clin Pract | 2010 | https://conductscience.org/library/papers/20618882 | PubMed |
| 20 | 23107353 | Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device. | Pediatr Diabetes | 2013 | https://conductscience.org/library/papers/23107353 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40718205 | The 'Designer' Artificial Pancreas: How Does Current Technology Mimic Pancreatic Physiology? | Cureus | 2025 | https://conductscience.org/library/papers/40718205 | PubMed |
| 36213069 | Vasodilatory effects of glucagon: A possible new approach to enhanced subcutaneous insulin absorption in artificial pancreas devices. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36213069 | PubMed |
| 28755444 | Bolusing frequency and amount impacts glucose control during hybrid closed-loop. | Diabet Med | 2018 | https://conductscience.org/library/papers/28755444 | PubMed |
| 27364997 | Coming of age: the artificial pancreas for type 1 diabetes. | Diabetologia | 2016 | https://conductscience.org/library/papers/27364997 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26328536
GET https://conductscience.org/api/papers/v1/26328536/references?page=2